dr. sabari on biomarkers of response to immunotherapy in advanced nsclc
Published 3 years ago • 159 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:30
dr. sabari discusses immunotherapy biomarkers in nsclc
-
1:14
dr. levy on investigational biomarkers of response to immunotherapy in nsclc
-
1:05
dr. sabari discusses role of immunotherapy in sclc
-
1:39
dr. sabari discusses the utility of liquid biopsies in lung cancer
-
1:35
dr. sabari on novel immunotherapy combos under investigation in nsclc
-
0:37
copy of dr. sabari on managing immune-related adverse events in lung cancer
-
0:49
dr. sabari on immunotherapy updates in small cell lung cancer
-
6:47
new biomarkers for response to immunotherapy
-
4:37
emerging biomarkers in lung cancer
-
5:40
the role of mutation burden as a biomarker in nsclc
-
42:53
biomarkers in cancer immunotherapy: how much do they matter?
-
5:36
immunotherapy in nsclc: an update on biomarkers
-
6:42
pseudoprogression with checkpoint inhibitors in non-small cell lung cancer
-
3:44
biomarkers for selection of immuno-oncology agents in nsclc
-
1:04
dr. mehnert on promising biomarkers for immunotherapy
-
1:16
dr. levy on positive and negative biomarkers for immunotherapy in lung cancer
-
2:01
dr. rimm on biomarker testing in lung cancer
-
5:58
how long to continue immunotherapy
-
1:18
scrna-seq of the immune microenvironment reveals immunotherapy response biomarkers in high-risk smm